1. Clinical practice Ljungberg B, European clinical 27 Jan guidelines Bensalah K, Canfield practice guidelines 2015 S, et al: EAU on the classification guidelines on renal of renal cell cell carcinoma: 2014 carcinoma providing update. Eur Urol levels of evidence for 67:913-24, 2015 the recommendations (adhering to Preferred Reporting Items for Systematic Reviews and analyses (PRISMA) guidelines). 2. Literature Koul H, Huh J-S, Rove Literature review of Molecular aspects of 2011 review KO, et al. Molecular current renal cell carcinoma: a aspects of renal cell epidemiology, review carcinoma: a review. pathophysiology, American Journal of evaluation, Cancer Research. treatment, and 2011;1(2):240-54. future research directions of RCC. 3. Observational Rare Cancers A review of available 2016 study Australia: Just a Little cancer data More Time Rare investigating the Cancers Update disparities existing Report. 2016 for incidence, mortality and survival across the cancer spectrum. The study provided a definition for rare cancers, and the burden of disease that rare and less common cancers pose across all ages in Australia 4. Health Sabatini LM, US Study by 2014 economics Mathews C, Ptak D, Association for study et al: Genomic Molecular Pathology Sequencing on cost and value Procedure analysis of specific Microcosting Analysis genomic sequencing and Health Economic procedures (GSPs) Cost-Impact Analysis: gathered from A Report of the representative Association for laboratories’ data. Molecular Pathology. Cost-impact models J of Mol Diagn for three clinical 18:319-328, scenarios were
1. Clinical practice guidelines Ljungberg B, Bensalah K, Canfield S, et al: EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67:913-24, 2015 European clinical practice guidelines on the classification of renal cell carcinoma providing levels of evidence for the recommendations (adhering to Preferred Reporting Items for Systematic Reviews and (PRISMA) guidelines). 27 Jan 2015 2. Literature review Koul H, Huh J-S, Rove KO, et al. Molecular aspects of renal cell carcinoma: a review. American Journal of Cancer Research. 2011;1(2):240-54. Literature review of current epidemiology, pathophysiology, evaluation, treatment, and future research directions of RCC. Molecular aspects of renal cell carcinoma: a review 2011 3. Observational study Rare Cancers Australia: Just a Little More Time Rare Cancers Update Report. 2016 A review of available cancer data investigating the disparities existing for incidence, mortality and survival across the cancer spectrum. The study provided a definition for rare cancers, and the burden of disease that rare and less common cancers pose across all ages in Australia 2016 4. Health economics study Sabatini LM, Mathews C, Ptak D, et al: Genomic Sequencing Procedure Microcosting Analysis and Health Economic Cost-Impact Analysis: A Report of the Association for Molecular Pathology. J of Mol Diagn 18:319-328, US Study by Association for Molecular Pathology on cost and value analysis of specific genomic sequencing procedures (GSPs) gathered from representative laboratories’ data. Cost-impact models for three clinical scenarios were 2014 analyses